[
    [
        {
            "time": "2023-10-01",
            "original_text": "Is UnitedHealth's Dividend Safe After a 16% Increase?",
            "features": {
                "keywords": [
                    "UnitedHealth",
                    "Dividend",
                    "Increase"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Is UnitedHealth's Dividend Safe After a 16% Increase?",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "3 Stocks to Buy After Recent Changes to Medicare",
            "features": {
                "keywords": [
                    "Stocks",
                    "Medicare",
                    "Changes"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "3 Stocks to Buy After Recent Changes to Medicare",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Rory McIlroy Helps UnitedHealthcare Launch Effort to Encourage Healthier Habits for Americans and Break a GUINNESS WORLD RECORDS™ Title for the Most Pledges Received for a Health Campaign in One Month",
            "features": {
                "keywords": [
                    "Rory McIlroy",
                    "UnitedHealthcare",
                    "Healthier Habits",
                    "GUINNESS WORLD RECORDS™"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Rory McIlroy Helps UnitedHealthcare Launch Effort to Encourage Healthier Habits for Americans and Break a GUINNESS WORLD RECORDS™ Title for the Most Pledges Received for a Health Campaign in One Month",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "FDA ‘shifting the bar’ for approval with new Alzheimer’s drug: Eli Lilly CEO",
            "features": {
                "keywords": [
                    "FDA",
                    "Alzheimer’s drug",
                    "Eli Lilly",
                    "approval"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "FDA ‘shifting the bar’ for approval with new Alzheimer’s drug: Eli Lilly CEO",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]